GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Research conducted by a local hospital has found that hepatitis B patients with a simple fatty liver have a lower mortality ...

Introduction: Steatotic liver disease (SLD) can worsen the prognosis of other chronic liver diseases, including viral hepatitis. Objectives: To compare SLD and non-SLD patients with chronic hepatitis ...

Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...

A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

TAIPEI (Taiwan News) — A study conducted by National Taiwan University Hospital has uncovered a link between hepatitis B, ...

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

Bluejay’s lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).